The proposed guidance aims to provide a framework for the approval of personalised mRNA-based cancer vaccines.

ATLANTA - Femasys Inc. (NASDAQ:FEMY), a biomedical company specializing in women's health, has announced the UK regulatory approval of three of its products: the FemaSeed Intratubal Insemination ...

The pathway allows medicine developers to work with the regulators, the NHS and health technology assessment bodies.

Nursing Times’ open access learning unit will teach nurses when and how to report suspected adverse drug reactions (ADRs) ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued new guidance on meeting UK medical devices ...

Surgical patients may still have leftovers in their system even after a standard fast, potentially increasing the chance of a ...

The MHRA has issued guidance to help manufacturers ensure that digital mental health technologies are effective, reliable and ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has launched a consultation on regulatory guidance for ...

Valneva’s chikungunya vaccine Ixchiq has been greenlit by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) ...

Glenmark Pharmaceuticals receives UK approval for Winlevi, a groundbreaking topical acne treatment with unique mechanism of ...